Preventive effects of bifemelane hydrochloride on decreased levels of muscarinic acetylcholine receptor and its mRNA in a rat model of chronic cerebral hypoperfusion

Yoichi Kondo, Norio Ogawa, Masato Asanuma, Koji Matsuura, Sakiko Nishibayashi, Emi Iwata

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Changes in muscarinic acetylcholine receptor (mACh-R) binding and muscarinic cholinergic ml receptor (ml-R) mRNA levels were determined in a rat model of cerebral hypoperfusion in which hypoperfusion was induced by permanent bilateral occlusion of the common carotid arteries. After 6 weeks of hypoperfusion, mACh-R binding activity was significantly reduced in the frontal cortex (79.0%, P <0.01), striatum (74.2%, P <0.01) and hippocampus (78.6%, P <0.01), and the ml-R mRNA levels in the frontal cortex (86.6%, P <0.05) and striatum (89.4%, P <0.05) compared with sham-operated control. Repeated administration of bifemelane hydrochloride (15 mg/kg/day, p.o., once a day from the day of operation for 6 weeks) prevented the hypoperfusion-induced loss of mACh-R binding and ml-R mRNA levels above described. Since the central cholinergic systems play an important role in learning and memory, these findings suggest that bifemelane hydrochloride is useful to treat and/or prevent vascular dementia which is closely related to cerebral hypoperfusion.

Original languageEnglish
Pages (from-to)409-414
Number of pages6
JournalNeuroscience Research
Volume24
Issue number4
DOIs
Publication statusPublished - Mar 1996

Fingerprint

Muscarinic Receptors
Frontal Lobe
Messenger RNA
Cholinergic Agents
Vascular Dementia
Common Carotid Artery
Cholinergic Receptors
Hippocampus
Learning
bifemelane

Keywords

  • 2VO
  • Bifemelane hydrochloride
  • Cholinergic system
  • Chronic cerebral hypoperfusion
  • Permanent occlusion
  • Vascular dementia

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Preventive effects of bifemelane hydrochloride on decreased levels of muscarinic acetylcholine receptor and its mRNA in a rat model of chronic cerebral hypoperfusion. / Kondo, Yoichi; Ogawa, Norio; Asanuma, Masato; Matsuura, Koji; Nishibayashi, Sakiko; Iwata, Emi.

In: Neuroscience Research, Vol. 24, No. 4, 03.1996, p. 409-414.

Research output: Contribution to journalArticle

@article{11424edc7cd74c5aa777f430f5283c51,
title = "Preventive effects of bifemelane hydrochloride on decreased levels of muscarinic acetylcholine receptor and its mRNA in a rat model of chronic cerebral hypoperfusion",
abstract = "Changes in muscarinic acetylcholine receptor (mACh-R) binding and muscarinic cholinergic ml receptor (ml-R) mRNA levels were determined in a rat model of cerebral hypoperfusion in which hypoperfusion was induced by permanent bilateral occlusion of the common carotid arteries. After 6 weeks of hypoperfusion, mACh-R binding activity was significantly reduced in the frontal cortex (79.0{\%}, P <0.01), striatum (74.2{\%}, P <0.01) and hippocampus (78.6{\%}, P <0.01), and the ml-R mRNA levels in the frontal cortex (86.6{\%}, P <0.05) and striatum (89.4{\%}, P <0.05) compared with sham-operated control. Repeated administration of bifemelane hydrochloride (15 mg/kg/day, p.o., once a day from the day of operation for 6 weeks) prevented the hypoperfusion-induced loss of mACh-R binding and ml-R mRNA levels above described. Since the central cholinergic systems play an important role in learning and memory, these findings suggest that bifemelane hydrochloride is useful to treat and/or prevent vascular dementia which is closely related to cerebral hypoperfusion.",
keywords = "2VO, Bifemelane hydrochloride, Cholinergic system, Chronic cerebral hypoperfusion, Permanent occlusion, Vascular dementia",
author = "Yoichi Kondo and Norio Ogawa and Masato Asanuma and Koji Matsuura and Sakiko Nishibayashi and Emi Iwata",
year = "1996",
month = "3",
doi = "10.1016/0168-0102(95)01017-3",
language = "English",
volume = "24",
pages = "409--414",
journal = "Neuroscience Research",
issn = "0168-0102",
publisher = "Elsevier Ireland Ltd",
number = "4",

}

TY - JOUR

T1 - Preventive effects of bifemelane hydrochloride on decreased levels of muscarinic acetylcholine receptor and its mRNA in a rat model of chronic cerebral hypoperfusion

AU - Kondo, Yoichi

AU - Ogawa, Norio

AU - Asanuma, Masato

AU - Matsuura, Koji

AU - Nishibayashi, Sakiko

AU - Iwata, Emi

PY - 1996/3

Y1 - 1996/3

N2 - Changes in muscarinic acetylcholine receptor (mACh-R) binding and muscarinic cholinergic ml receptor (ml-R) mRNA levels were determined in a rat model of cerebral hypoperfusion in which hypoperfusion was induced by permanent bilateral occlusion of the common carotid arteries. After 6 weeks of hypoperfusion, mACh-R binding activity was significantly reduced in the frontal cortex (79.0%, P <0.01), striatum (74.2%, P <0.01) and hippocampus (78.6%, P <0.01), and the ml-R mRNA levels in the frontal cortex (86.6%, P <0.05) and striatum (89.4%, P <0.05) compared with sham-operated control. Repeated administration of bifemelane hydrochloride (15 mg/kg/day, p.o., once a day from the day of operation for 6 weeks) prevented the hypoperfusion-induced loss of mACh-R binding and ml-R mRNA levels above described. Since the central cholinergic systems play an important role in learning and memory, these findings suggest that bifemelane hydrochloride is useful to treat and/or prevent vascular dementia which is closely related to cerebral hypoperfusion.

AB - Changes in muscarinic acetylcholine receptor (mACh-R) binding and muscarinic cholinergic ml receptor (ml-R) mRNA levels were determined in a rat model of cerebral hypoperfusion in which hypoperfusion was induced by permanent bilateral occlusion of the common carotid arteries. After 6 weeks of hypoperfusion, mACh-R binding activity was significantly reduced in the frontal cortex (79.0%, P <0.01), striatum (74.2%, P <0.01) and hippocampus (78.6%, P <0.01), and the ml-R mRNA levels in the frontal cortex (86.6%, P <0.05) and striatum (89.4%, P <0.05) compared with sham-operated control. Repeated administration of bifemelane hydrochloride (15 mg/kg/day, p.o., once a day from the day of operation for 6 weeks) prevented the hypoperfusion-induced loss of mACh-R binding and ml-R mRNA levels above described. Since the central cholinergic systems play an important role in learning and memory, these findings suggest that bifemelane hydrochloride is useful to treat and/or prevent vascular dementia which is closely related to cerebral hypoperfusion.

KW - 2VO

KW - Bifemelane hydrochloride

KW - Cholinergic system

KW - Chronic cerebral hypoperfusion

KW - Permanent occlusion

KW - Vascular dementia

UR - http://www.scopus.com/inward/record.url?scp=0029913848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029913848&partnerID=8YFLogxK

U2 - 10.1016/0168-0102(95)01017-3

DO - 10.1016/0168-0102(95)01017-3

M3 - Article

C2 - 8861111

AN - SCOPUS:0029913848

VL - 24

SP - 409

EP - 414

JO - Neuroscience Research

JF - Neuroscience Research

SN - 0168-0102

IS - 4

ER -